A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2002
11/14/2002	CA2446640A1 .beta.-amyloid peptide-binding proteins and polynucleotides encoding the same
11/14/2002	CA2446458A1 Toll/interleukin-1 receptor adaptor protein (tirap)
11/14/2002	CA2446437A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
11/14/2002	CA2446204A1 Anti-virus agent
11/14/2002	CA2446062A1 Mixture of peptides derived from e6 and/or e7 papillomavirus proteins and uses thereof
11/14/2002	CA2446036A1 A method for transfection of rna using electrical pulses
11/14/2002	CA2445982A1 Sperm-specific cation channel, and uses therefor
11/14/2002	CA2445381A1 Phosphorous containing antimicrobial compounds and methods for their use
11/13/2002	EP1256589A2 Oligomers containing modified pyrimidines
11/13/2002	EP1255864A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255850A1 AMPLIFICATION OF $i(CYP24) AND USES THEREOF
11/13/2002	EP1255849A2 Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses
11/13/2002	EP1255845A2 Modified cytokines for use in cancer therapy
11/13/2002	EP1255837A2 Il-17 like molecules and uses thereof
11/13/2002	EP1255835A2 Polypeptides and nucleic acids encoding same
11/13/2002	EP1255833A2 Polypeptides and nucleic acids encoding same
11/13/2002	EP1255829A2 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization
11/13/2002	EP1255828A2 Small oligonucleotides with anti-tumor activity
11/13/2002	EP1255827A2 Novel oligonucleotides and use of oligonucleotides modulating the expression of enzymes involved in the synthesis of melanic pigments, as depigmentation agents
11/13/2002	EP1255822A2 Modified adenylylcyclase type vi useful in gene therapy for congestive heart failure
11/13/2002	EP1255821A2 Protein c derivatives
11/13/2002	EP1255819A2 Human kinases
11/13/2002	EP1255817A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255778A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255777A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255776A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255768A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255767A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255766A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255569A2 Method for treating kidney disorders
11/13/2002	EP1255559A2 Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease (cad) for treating cardiac disease
11/13/2002	EP1255555A2 NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY
11/13/2002	EP1255550A2 Method for identifying and using a 2b adenosine receptor antagonists to mediate mammalian cell proliferation
11/13/2002	EP1060261A4 Poly zinc finger proteins with improved linkers
11/13/2002	EP0814777B1 Stable lipid-comprising drug delivery complexes and methods for their production
11/13/2002	EP0738281B1 Peptides and their uses against psoriasis
11/13/2002	CN1379821A Nucleic acid transporter containing polypeptide and recombinant virus vector
11/13/2002	CN1379820A Lentiviral vectors for preparation of immunotherapeutical compositions
11/13/2002	CN1379817A Composition and methods for increasing cholesterol efflux and raising HDL using ATP binding cassettte ttansporter protein ABC1
11/13/2002	CN1379816A Human G-protein coupled receptor
11/13/2002	CN1379814A Embryonic or stem-like cell lines produced by cross species nuclear transpcantation and methods for enhancing mebryonic development by genetic alteration of donor cells or by tissue culture conditions
11/13/2002	CN1379682A Use of outer membrane protein of enterobacterium associated with RSV immunogeni peptide for preparing vaccines for intranasal administration
11/13/2002	CN1379681A therapeutic angiogenic factors and methods for their use
11/13/2002	CN1379109A Adenovirus carrier for specifically killing primary liver cancer cells and its application
11/12/2002	US6479654 Forms of the angiogenic factor vascular endothelial cell growth factor: VEGF
11/12/2002	US6479640 Antibody specific for a protein tyrosine phosphatase that localizes to focal adhesions
11/12/2002	US6479633 Chemokine alpha 2
11/12/2002	US6479630 Human purinergic P2U receptor
11/12/2002	US6479628 Methods and materials relating to IMPDH and GMP production
11/12/2002	US6479626 Poly zinc finger proteins with improved linkers
11/12/2002	US6479465 Methods of treating colitis using STAT-4 anti-sense oligonucleotides
11/12/2002	US6479464 Polypeptide comprising of the following 29 amino acid composition: 6g's, 2f's, 2l's, 1w, 4r's, 2e's, 2n's, 3k's, 1t, 1s, 1a, 1y, 1m, 1c, and 1i, and additional cationic residues to provide a net number of positive charges of at least 8
11/12/2002	US6479292 Genetic alteration in plants using single-stranded oligodeoxynucleotide vectors
11/12/2002	US6479290 Chimeric adenoviral vectors
11/12/2002	US6479284 Humanized antibody and uses thereof
11/12/2002	US6479281 Infectious pseudotyped lentiviral vectors lacking matrix protein and uses thereof
11/12/2002	US6479273 Filtration method for separating viruses
11/12/2002	CA2271781C Use of cntf (ciliary neurotrophic factor) receptor activators for the treatment of obesity
11/12/2002	CA2169635C Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides
11/12/2002	CA2088917C Therapeutic ribozyme compositions
11/07/2002	WO2002088384A1 Screening method
11/07/2002	WO2002088370A2 Autogene nucleic acids encoding a secretable rna polymerase
11/07/2002	WO2002088366A1 Von willebrand factor (vwf)-cleaving enzyme
11/07/2002	WO2002088363A2 Regulation of novel human prolyl 4-hydroxylases
11/07/2002	WO2002088352A2 Schwann cell specific enhancer and methods of use thereof
11/07/2002	WO2002088345A2 Murine dnasex, medicament containing the same and non-human mammal comprising modified dnasex gene
11/07/2002	WO2002088336A2 Genetically modified yt cell line and use thereof
11/07/2002	WO2002088327A1 Methods for viral oncoapoptosis in cancer therapy
11/07/2002	WO2002088323A2 Gene delivery compounds
11/07/2002	WO2002088319A2 Mini-adenoviral vector and methods of using same
11/07/2002	WO2002088318A2 Lipid-comprising drug delivery complexes and methods for their production
11/07/2002	WO2002088317A2 Fusion molecules and methods for treatment of immune diseases
11/07/2002	WO2002088314A2 Ovary-specific genes and proteins
11/07/2002	WO2002088304A2 Compositions and methods for suppressing immune responses
11/07/2002	WO2002088181A2 Mrp8/mrp14 heterodimer, or its individual components in combination, for treating and/or preventing skin diseases, wounds and/or wound-healing disturbances
11/07/2002	WO2002088180A2 Use of alpha 1-antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds
11/07/2002	WO2002088173A2 Viral-mediated delivery and in vivo expression of polynucleotides encoding anti-angiogenic proteins
11/07/2002	WO2002088163A1 Antisense modulation of interferon gamma receptor 2 expression
11/07/2002	WO2002087625A1 Composite oncolytic herpes virus vectors
11/07/2002	WO2002087623A1 Microparticle protection of therapeutic agents
11/07/2002	WO2002087614A2 Multivalent vaccine comprising an hiv antigen and an hsv antigen and/or an hpv antigen
11/07/2002	WO2002087607A1 Use of agt and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions
11/07/2002	WO2002087594A1 Non-viral vesicle vector for cardiac specific gene delivery
11/07/2002	WO2002087510A2 Subcellular targeting of therapeutic proteins
11/07/2002	WO2002087509A2 Colloidal metal compositions and methods
11/07/2002	WO2002087496A2 Methods for inhibiting macrophage colony stimulating factor and c-fms-dependent cell signaling
11/07/2002	WO2002087472A1 Stent-based delivery of statins to prevent restenosis
11/07/2002	WO2002087419A2 Biological pacemaker
11/07/2002	WO2002087341A1 Novel self-inactivating (sin) lentiviral vectors
11/07/2002	WO2002087336A1 Foot and mouth disease virus vaccine
11/07/2002	WO2002074980A3 Muteins of hypoxia inducible factor alpha and methods of use thereof
11/07/2002	WO2002068614A3 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas
11/07/2002	WO2002052016A3 Regulation of human protein l-isoaspartate o-methyltransferase-like enzyme
11/07/2002	WO2002028897A3 Human g-protein coupled receptor and uses thereof
11/07/2002	WO2002024930A3 Artificial ubiquitous chromatin opening elements (ucoe)
11/07/2002	WO2002020565A3 Collections of repeat proteins comprising repeat modules
11/07/2002	WO2002002600A3 HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR27, AND USES THEROF
11/07/2002	WO2001086002A9 Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis
11/07/2002	WO2001073056A3 Regulation of human oxoprolinase-like enzyme
11/07/2002	WO2001057086A9 Novel human g protein coupled receptor proteins and polynucleotides encoding the same

1 ... 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 ... 870